Healthcare provider profile · identity verified

Marlon Alando Clarke, M.D

Family Practice · COLUMBIA, SC · NPI 1629366166

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	853	63
Atorvastatin Calcium	Atorvastatin Calcium	797	59
Sertraline Hcl	Sertraline Hcl	540	36
Ipratropium Bromide	Ipratropium Bromide	491	386
Gabapentin	Gabapentin	447	48
Levothyroxine Sodium	Levothyroxine Sodium	444	30
Eliquis	Apixaban	412	37
Losartan Potassium	Losartan Potassium	381	25
Pravastatin Sodium	Pravastatin Sodium	372	15
Furosemide	Furosemide	357	34
Tamsulosin Hcl	Tamsulosin Hcl	350	28
Allopurinol	Allopurinol	343	15
Trazodone Hcl	Trazodone Hcl	330	32
Metoprolol Succinate	Metoprolol Succinate	329	27
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	311	255
Donepezil Hcl	Donepezil Hcl	306	23
Carvedilol	Carvedilol	287	26
Pantoprazole Sodium	Pantoprazole Sodium	282	35
Potassium Chloride	Potassium Chloride	276	20
Omeprazole	Omeprazole	262	21
Clopidogrel	Clopidogrel Bisulfate	223	19
Prednisone	Prednisone	220	151
Levetiracetam	Levetiracetam	215	17
Mirtazapine	Mirtazapine	212	21
Metformin Hcl	Metformin Hcl	208	19
Risperidone	Risperidone	198	13
Rosuvastatin Calcium	Rosuvastatin Calcium	191	14
Metoprolol Tartrate	Metoprolol Tartrate	188	19
Baclofen	Baclofen	173	suppressed
Lisinopril	Lisinopril	146	14
Hydralazine Hcl	Hydralazine Hcl	138	12
Carbidopa-Levodopa	Carbidopa/Levodopa	129	suppressed
Famotidine	Famotidine	123	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	116	93
Escitalopram Oxalate	Escitalopram Oxalate	115	suppressed
Naproxen	Naproxen	109	92
Doxycycline Monohydrate	Doxycycline Monohydrate	108	96
Divalproex Sodium	Divalproex Sodium	106	suppressed
Clindamycin Hcl	Clindamycin Hcl	105	93
Finasteride	Finasteride	102	suppressed
Ropinirole Hcl	Ropinirole Hcl	97	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	94	71
Dexamethasone	Dexamethasone	89	87
Bupropion Xl	Bupropion Hcl	86	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	84	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	84	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	78	62
Montelukast Sodium	Montelukast Sodium	73	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	73	59
Benztropine Mesylate	Benztropine Mesylate	72	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	71	suppressed
Primidone	Primidone	70	suppressed
Buspirone Hcl	Buspirone Hcl	69	suppressed
Brilinta	Ticagrelor	68	suppressed
Nifedipine Er	Nifedipine	67	suppressed
Alendronate Sodium	Alendronate Sodium	66	suppressed
Duloxetine Hcl	Duloxetine Hcl	66	suppressed
Propranolol Hcl	Propranolol Hcl	64	suppressed
Xarelto	Rivaroxaban	62	suppressed
Memantine Hcl	Memantine Hcl	61	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	17
Citalopram Hbr	Citalopram Hydrobromide	59	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	59	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	59	46
Quetiapine Fumarate	Quetiapine Fumarate	58	suppressed
Latanoprost	Latanoprost	56	12
Valsartan	Valsartan	55	suppressed
Calcitriol	Calcitriol	54	suppressed
Midodrine Hcl	Midodrine Hcl	54	suppressed
Digoxin	Digoxin	51	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	50	suppressed
Lamotrigine	Lamotrigine	49	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	48	40
Olanzapine	Olanzapine	48	suppressed
Trulicity	Dulaglutide	48	suppressed
Fluconazole	Fluconazole	47	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	35
Metformin Hcl Er	Metformin Hcl	47	suppressed
Simvastatin	Simvastatin	44	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	suppressed
Prazosin Hcl	Prazosin Hcl	41	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Amantadine	Amantadine Hcl	39	suppressed
Carbamazepine	Carbamazepine	39	suppressed
Jardiance	Empagliflozin	39	suppressed
Ramelteon	Ramelteon	39	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	38	suppressed
Benazepril Hcl	Benazepril Hcl	37	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	25
Acarbose	Acarbose	35	suppressed
Bupropion Hcl Sr	Bupropion Hcl	35	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	35	suppressed
Dutasteride	Dutasteride	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Myrbetriq	Mirabegron	35	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Paliperidone Er	Paliperidone	35	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	35	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	35	15
Valproic Acid	Valproic Acid	35	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	35	suppressed
Amiodarone Hcl	Amiodarone Hcl	33	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	33	30
Divalproex Sodium Er	Divalproex Sodium	30	suppressed
Nuplazid	Pimavanserin Tartrate	30	suppressed
Aripiprazole	Aripiprazole	28	suppressed
Metronidazole	Metronidazole	27	15
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	26	suppressed
Ondansetron Odt	Ondansetron	26	22
Scopolamine	Scopolamine	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Ketoconazole	Ketoconazole	25	19
Memantine Hcl Er	Memantine Hcl	25	suppressed
Methimazole	Methimazole	25	suppressed
Minoxidil	Minoxidil	25	suppressed
Nystatin	Nystatin	25	20
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	18
Meclizine Hcl	Meclizine Hcl	22	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	21	suppressed
Isosorbide Dinit-Hydralazine	Isosorbide Dinit/Hydralazine	21	suppressed
Lurasidone Hcl	Lurasidone Hcl	21	suppressed
Linzess	Linaclotide	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	14
Levofloxacin	Levofloxacin	19	13
Lidocaine Hcl	Lidocaine Hcl	19	13
Lokelma	Sodium Zirconium Cyclosilicate	19	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Atenolol	Atenolol	17	suppressed
Cephalexin	Cephalexin	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	16	13
Lovastatin	Lovastatin	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Vancomycin Hcl	Vancomycin Hcl	16	suppressed
Azithromycin	Azithromycin	15	13
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Ozempic	Semaglutide	12	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Gemtesa	Vibegron	11	suppressed
Lactulose	Lactulose	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error